October 20, 2025

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Promising Biotech with a 100.7% Revenue Growth and Robust Analyst Support

Ionis Pharmaceuticals, Inc. (IONS) is making waves in the healthcare sector, particularly within the biotechnology industry. The company, headquartered in Carlsbad, California, is a commercial-stage firm specializing in RNA-targeted medicines...

STERIS plc (STE) Stock Analysis: Exploring a 13.39% Potential Upside in the Medical Devices Sector

Investors keeping a keen eye on the healthcare sector should take a closer look at STERIS plc (NYSE: STE), a prominent player in the medical devices industry. With a market..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unlocking Potential with a 19.87% Upside

TransMedics Group, Inc. (NASDAQ: TMDX), a healthcare company specializing in medical devices for organ transplants, is making waves in the investor community. With a market capitalization of $4.01 billion, TransMedics..

Regencell Bioscience Holdings L (RGC) Stock Analysis: A High-Risk, High-Reward Play in the TCM Sector

In the evolving landscape of healthcare, Regencell Bioscience Holdings L (RGC) stands out as a unique player in the Traditional Chinese Medicine (TCM) sector. Specializing in the treatment of neurocognitive..

Solventum Corporation (SOLV) Stock Analysis: Examining a 17.95% Potential Upside for Healthcare Investors

For investors with a keen eye on the healthcare sector, Solventum Corporation (SOLV) presents itself as a compelling opportunity. With a market capitalization of $12.51 billion, this Minnesota-based company operates..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a 29% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a notable player in the healthcare plan sector, currently trades at $19.39, reflecting a marginal dip of 0.08% in its recent price change. While its..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 25.67% Upside Amidst Strong Revenue Growth

TG Therapeutics, Inc. (TGTX), a prominent player in the biotechnology sector, is making waves with its focus on innovative treatments for B-cell mediated diseases. With a market capitalization of $5.5..

Waters Corporation (WAT) Stock Analysis: A Promising 5.92% Potential Upside for Healthcare Investors

Waters Corporation (NYSE: WAT), a significant player in the healthcare sector, particularly within the diagnostics and research industry, presents an intriguing opportunity for investors. With a market capitalization of $19.92..

Alcon Inc. (ALC) Stock Analysis: Healthcare Titan Offers 27% Upside Potential

As a cornerstone of the medical instruments and supplies industry, Alcon Inc. (NYSE: ALC) stands as a formidable player in the global eye care market. With a market capitalization of..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with a 49.67% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands at the forefront of the healthcare sector, specializing in diagnostic and therapeutic products that aid clinicians in diagnosing and treating a variety of diseases,..

Biogen Inc. (BIIB) Stock Analysis: A 20.52% Potential Upside Amidst Robust Product Line

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, is capturing investor attention with its promising potential upside of 20.52%. As a leading figure in the drug manufacturing industry,..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Powerhouse with a 71.88% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, is drawing investor attention with its impressive market cap of $8.29 billion and a promising pipeline of treatments..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Analyst Consensus Indicates Strong “Buy” with Significant Growth Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a Boston-based biopharmaceutical company, is capturing the attention of investors with its promising focus on treating rare neuroendocrine diseases. With a market capitalization of $7.32..

AstraZeneca PLC (AZN) Stock Analysis: Navigating Growth with a 6% Upside Potential

AstraZeneca PLC (AZN), a titan in the healthcare sector, continues to make significant strides in the pharmaceutical industry. Headquartered in Cambridge, UK, AstraZeneca is a key player in the discovery,..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 26% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the global healthcare sector, is drawing investor attention with its significant potential upside of 26.27%. As a Spanish-based plasma therapeutic company, Grifols..

Teleflex Incorporated (TFX) Stock Analysis: A Healthcare Giant with Modest Growth Potential

Teleflex Incorporated (NYSE: TFX) is a notable player in the medical instruments and supplies industry, offering a wide range of single-use medical devices that cater to critical care and surgical..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A 37.91% Upside Potential Amidst Robust Buy Ratings

Jazz Pharmaceuticals plc (JAZZ), a prominent player in the biotechnology sector, has captured investor attention with its promising potential upside of 37.91%, as indicated by recent analyst ratings. Headquartered in..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unpacking a 29% Upside Potential in Biotech Innovation

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, has been capturing investor attention with its innovative approach to treating debilitating diseases through muscle activators and inhibitors. Headquartered..

Legend Biotech Corporation (LEGN) Stock Analysis: Significant Upside Potential with an Average Target Price of $75.06

Legend Biotech Corporation (NASDAQ: LEGN) is a prominent player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $5.9 billion, the company is headquartered in..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Insight on Its 8.62% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $20.19 billion, this U.S.-based..

Search

Funds

October 20, 2025

Search

Funds

October 20, 2025

FTSE 100

Funds